Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Total Costs & Expenses

$11.56B

TTM · Period ending: Jun 30, 2026 · USD

REGN Total Costs & Expenses

Latest reported$11.56Bperiod endingJun 30, 2026

Latest reported$11.56Bperiod endingJun 30, 2026

REGN TTM Total Costs & Expenses (-$8.30M → $11.56B)

TTM Total Costs & Expenses

High-resolution chart · PNG

REGN total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	93,302,000
Mar 31, 2001	87,869,000
Dec 31, 2000	85,823,000
Sep 30, 2000	69,497,000
Jun 30, 2000	66,409,000
Mar 31, 2000	62,278,000
Dec 31, 1999	58,100,000
Sep 30, 1999	59,100,000
Jun 30, 1999	55,900,000
Mar 31, 1999	54,400,000
Dec 31, 1998	51,000,000
Sep 30, 1998	47,600,000
Jun 30, 1998	44,400,000
Mar 31, 1998	41,900,000
Dec 31, 1997	40,800,000
Sep 30, 1997	41,600,000
Jun 30, 1997	42,200,000
Mar 31, 1997	41,800,000
Dec 31, 1996	41,400,000
Sep 30, 1996	38,900,000
Jun 30, 1996	36,900,000
Mar 31, 1996	35,900,000
Dec 31, 1995	35,000,000
Sep 30, 1995	39,300,000
Jun 30, 1995	43,300,000
Mar 31, 1995	48,000,000
Dec 31, 1994	52,400,000
Sep 30, 1994	53,700,000
Jun 30, 1994	54,000,000
Mar 31, 1994	51,500,000
Dec 31, 1993	49,400,000
Sep 30, 1993	43,700,000
Jun 30, 1993	38,800,000
Mar 31, 1993	34,400,000
Dec 31, 1992	29,800,000
Sep 30, 1992	27,100,000
Jun 30, 1992	23,500,000
Mar 31, 1992	20,500,000
Dec 31, 1991	13,800,000
Sep 30, 1991	-200,000
Jun 30, 1991	-4,600,000
Mar 31, 1991	-8,300,000
Dec 31, 1990	-8,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.